ArticleCureus2026
Primary Localized Amyloidosis of the Urinary Bladder Mimicking Urothelial Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary localized amyloidosis of the urinary bladder is a rare benign condition that can closely mimic urothelial carcinoma clinically and cystoscopically, particularly in patients presenting with visible hematuria. We report the case of a 79-year-old gentleman with persistent visible hematuria who underwent flexible cystoscopy, computed tomography urography, transurethral resection of bladder tumor, histopathological assessment, thoracic imaging, and hematological evaluation, including serum free light chain analysis. Cystoscopy revealed a suspicious bladder lesion concerning for malignancy, but histopathology demonstrated localized amyloid deposition within the bladder wall without evidence of urothelial carcinoma. Subsequent imaging and hematological work-up showed no evidence of systemic amyloidosis, and multidisciplinary review supported a diagnosis of primary localized bladder amyloidosis. The patient recovered without perioperative complications and was advised long-term cystoscopic surveillance because of the risk of recurrence. This case highlights localized bladder amyloidosis as an important differential diagnosis for persistent visible hematuria and suspicious bladder lesions, emphasizing the need for histopathological confirmation and exclusion of systemic disease to avoid unnecessary radical intervention while ensuring appropriate follow-up.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.